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Programa de Control de la Tuberculosis bovina: 
Aspectos a considerar en su etapa final.
Introducción
La Academia Nacional de 
Agronomía y Veterinaria y el Centro 
Nacional de Investigaciones Agro­
pecuarias de INTA, Castelar, realizaron 
una Sesión Pública en la sede de la 
Academia el día 6 de abril de 2000, 
destinada a informar sobre avances de 
investigación en Tuberculosis Bovina 
en los EEUU y su aplicación en 
programas de control.
Para tal fin contaron con la 
participación como disertante del Dr. 
M.V. Mo Salman, Profesor de 
Epidemiología Veterinaria, Colorado 
State University, Fort Collins, Colorado, 
USA.
El Dr. Salman estaba en el 
país como experto y consultor en el 
marco de un proyecto de investigación 
sobre “Mejoramiento del Diagnóstico 
de la Tuberculosis Bovina en 
Rumiantes” proyecto elaborado por los 
técnicos de los Institutos de 
Patobiología y B iotecnología del 
Centro de Investigación en Ciencias 
Veterinarias y Agronómicas del CNIA- 
INTA, Castelar, bajo la coordinación 
del Dr. Jorge Pereira y que se 
desarrolla con el apoyo de la Agencia 
Internacional de Energía Atómica 
(AIEA) de Viena, Austria.
Esta tem ática tiene sus 
antecedentes en la ANAyV con un 
proyecto compartido en el período 
1995/1999 entre el Instituto de 
Patobiología, CICV-INTA, Castelar y la 
Academia Nacional de Agronomía y
Veterinaria, la cual aportó los recursos 
financieros para la realización del 
mismo. Dicho proyecto fue coordinado 
por el Académico Dr. Bernardo J. 
Carrillo, conjuntamente con los Dres. 
Jorge Pereira y Lucio Villa y con la 
participación de los técnicos Dra. Celia 
Antognoli, Méd.Vet. Sergio Garbaccio 
y Dra. Alicia Alito del Instituto de 
Patobiología del INTA, Castelar y de 
cuyos resultados se informó en 
comunicación aparte.
Dada la importancia del tema 
y el nivel del disertante, asistió una 
calificada concurrencia entre ellos 
académicos especia listas y 
profesionales veterinarios de diversas 
instituciones y de la actividad privada, 
de la capital y el interior del país.
La apertura del acto estuvo a 
cargo del Presidente de la ANAyV, Dr. 
Norberto Ras, quien después de 
diversas consideraciones sobre la Tu­
berculosis y su trascendencia como 
zoonosis, fue secundado por el 
epidemiólogo Dr. Sergio Duffy de INTA 
en la presentación del disertante Dr. 
Salman y de su trayectoria como 
investigador y consultor internacional.
A continuación disertó el Prof. 
Salman, recibiendo al fina liza r 
numerosas preguntas que respondió 
con toda idoneidad, terminando su 
presentación con los elogios de la
concurrencia por la claridad de los 
conceptos y el nivel de la disertación 
que se transcribe a continuación en 
su idioma original para conservar 
fidelidad.
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Disertación del Dr. Mo Salman DVM, Ph.D., DACVPM, 
F.A.C.E. Professor of Veterinary Epidemiology *
Bovine Tuberculosis Control Program: 
Issues to be considered for its final stage 
Mr. President, 
Colleagues,
It is a great honor and distinction to be received by the Academia Nacional 
de Agronomía y Veterinaria of Argentina to which I extend my respectful 
thanks.
Outline:
• Available options for the Bovine TB 
(BTB) Control Program
• Current measures and status of the 
USA TB Control Program
• Obstacles to the eradication efforts
■ Research findings and their implica­
tions in the current eradication efforts
• Our laboratory research activities: 
current and future directions
What are the current options to con­
trol BTB?
I will list options that are familiar to most 
of you. I will attempt to identify the limi­
tations of these options as I list them:
• Screening and elimination of suspect 
and infected animals/herds (Test and 
slaughter option):
• Depends on the sensitivity and speci­
ficity of the detection system (skin test 
and other epidemiological historical 
background)
■ Sacrificing animals and destroying 
herds that are not infected but they are
positive on the detection system (i.e., 
false positive)
■ It is hard to implement in the last stage 
of the disease eradication program
• The industry has to buy in, otherwise
the program cannot succeed.
• Certification process of herds that are 
free from the disease
• It requires a highly sensitive system 
so that the negative herds are surely 
without the infection. Thus, the speci­
ficity of the system will suffer (more false 
positive herds).
■ It requires some incentive for herd 
owners to maintain certification.
• Animal health authorities in the coun­
try should maintain a close monitoring 
of the “non-certified” herds and encour­
age the certification process. This will 
lead to reduction in the number of herds 
that can spread the infection.
■ It is hard to maintain good observa­
tions on the non-certified herds. Com­
pliance is a serious problem in these 
herds.
• Elimination of potential transmission 
of the disease to human populations 
through pasteurization and detection 
of TB lesions in slaughterhouses.
• This option will focus on the public 
health aspect and ignore the potential 
losses in cattle production due to this 
disease.
• It requires laws/regulations for mar­
keting milk and meat in the country.
• It requires a sensitive system for
* msalman@vth.colostate.edu 
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detection of suspect TB lesions in 
slaughterhouses. Training of meat in­
spectors is an essential part of this sys­
tem.
• It is a good option combining it with 
others in the last stage of the eradica­
tion phase.
• Trace back infection through the de­
tection ofTB lesions in slaughterhouses
• It requires a sensitive system for de­
tection of suspect TB lesions in slaugh­
terhouses. Training of meat inspectors 
is an essential part of this system.
• It requires an extensive identification 
system of herd origin in order to be able 
to trace infection to the original herds.
• It depends on the detection of infec­
tion ONLY through slaughter animals 
and there is a possibility to miss or de­
lay the detection of infection which can 
lead to a serious problem of spreading 
the disease.
■ It can work well when the infection 
rate in the country is reaching a low 
level (i.e. less than 1%)
• Trace back infection through a sero­
logical testing of cattle populations in 
the country.
• This option is valid when there is an 
existing system for the collection of se­
rum samples for other diseases such 
as brucellosis.
• It depends on the validity of the used 
serological test to detect/screen for the 
infection.
■ It is a valid option for a low cost pro­
gram but it would require an intensive 
monitoring for the test validity.
• Quarantine infected herds until the 
disease is cleared.
• This option is used in a low preva­
lence country with the availability of a 
highly specific detection system and 
the absence of the depopulation op­
tion.
■ It is of value when infected herds are 
valuable to the cattle industry in the 
country such as pure breed herds etc.
• It would require an intensive testing 
and monitoring of these herds to re­
duce the introduction of the disease to 
other herds.
• Let the disease take its course (live 
with it).
• It is a valid option when the disease 
prevalence is high and a veterinary in­
frastructure is absent in the country.
• I believe that the disease prevalence 
will be reduced to a certain level mainly 
due to poor production performance of 
infected herds and animals.
• The disease, however, will maintain 
a high infection rate and the country in 
general will suffer.
Conclusion/suggestions: Several of 
these options are combined in order 
to optimize the overall benefits. The 
major reasons for choosing some 
options rather than others are costs 
and practicality.
What is the current status of BTB in 
USA?
• The number of infected herds in the 
USA is currently 3.
• The number of states in which the dis­
ease is present is 2.
•The program is strictly dependent on 
identifying infection through detectable 
lesions in slaughterhouses. Cash in­
centive is given to meat inspectors who 
identify TB lesions if the infection is con­
firmed. The current level of confirma­
tion of these lesions is 20-30%.
• Culture and/or histopathological find­
ings are considered for the confirma­
tion of infection. A new PCR technique 
was included last year as part of the 
confirmatory tests for infection. This 
PCR that will confirm a histological
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lesion with the presence of acid-fast 
bacteria. Thus, histological preparation 
of the lesion is still required.
• Both caudal fold and comparative cer­
vical tests are used to declare an ani­
mal as a reactor. There are specific 
Uniform Rules and Methods that should 
be followed to classify infected herds.
• Indemnity is paid to owners with 
infected herds if the depopulation op­
tion is chosen. The indemnity price, 
however, is not up to the market price 
and owners are not happy for this op­
tion. Other options are considered to 
eliminate the infection from specific 
herds.
• Milk ordinance is in place in only a 
couple of states. The milk ordinance 
program would require every dairy 
herd to have a tuberculin testing (cau­
dal fold) every three-years.
• Due to the impact of other animal 
species on the spread of the disease, 
two other BTB programs are in place: 
Captive/farm cervids and bison. Both 
of these programs were just recently 
implemented and passed both the in­
dustry and governm ent approval. 
These two programs, however, use 
certain modified rules and tests that are 
adapted from the existing cattle pro­
gram.
Conclusion: Several progressive steps 
toward controlling the disease in USA 
have been accomplished.The disease, 
however, has not been eradicated and 
some States are getting new infections 
rather than maintaining their disease 
free status.
How far are we from the eradication 
of the disease in the USA?
It depends on the definition of eradica­
tion ... Is it the eradication of Myco­
bacterium bovis or the eradication of 
BTB from domesticated cattle? If it is
the latter then I think the country is al­
most there, if the former then it is far 
from reaching that goal.
What are the reasons for not reach­
ing the eradication status of the dis­
ease in the USA?
■ The last stage of the eradication 
phase is not an easy task due to sev­
eral reasons such as the lack of inter­
est, reduction in the confidence level 
of the detection of infection (poor pre­
dictive value of positive), difficulty in the 
location of infected herds, and lack of 
political and financial support.
• Existing screening and diagnostic 
tests were developed for a relatively 
high prevalence level of the disease. 
When the disease prevalence is low, 
these tests by their nature will have a 
poor predictive value of positive. Thus, 
the proportions of false positive ani­
mals/herds are increased. This prob­
lem by itself reduces the effectiveness 
and validity of the eradication program. 
Thus, there is a need to improve the 
existing tests to accommodate the low 
prevalence level of the disease. We will 
talk about this issue later.
• The bacterium itself has identified a 
better way to survive by finding a niche 
in other species particularly other ru­
minants. Deer, elk, and bison are ex­
amples of animals that harbor M. bovis 
and the bacterium is maintaining a 
good harmony with nature. Further­
more, we have manipulated the man­
agement style of these mainly wild 
species which increases the opportu­
nity for this bacterium to adapt to these 
animal species. We have started to 
manage these wild species in an in­
tensive way so that the environmental 
conditions for the bacterium to survive 
are almost perfect.
• The interaction between wild animals 
and cattle has increased due to
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several factors beyond this talk. This 
interaction has lead to a creation of an 
environment for the transmission of this 
bacterium between wild and domesti­
cate animals.
• Low public concerns about the threat 
of this disease to public health, Unfor­
tunately, the existing monitoring of hu­
man TB in the USA identifies the causal 
bacteria for cases by general category 
as M.TB complex. Thus, little is known 
about the impact of M. bovis in human 
infection.
• Low priority from both government 
and industry sectors due to low level of 
the disease.
Conclusion: There is a need to re­
evaluate the situation of the existing 
rules and policy toward the eradica­
tion program. Scientifically and socially 
based approaches need to be ex­
plored in order to reach the ultimate 
goal of eradicating the disease from 
the USA.
How much research has been done 
to evaluate options to control/ 
eradicate BTB?
• During the last two decades, several 
research projects were conducted in 
various parts of the world to evaluate 
diagnostic/screening tests, evaluate 
the role of mammalian reservoirs, de­
termine potential risk factors associated 
with the spread of the disease, and 
determine the source of epidemics and 
outbreaks of the disease. Most of these 
efforts, however, were narrowly focused 
on local geographical areas. For in­
stance, the work in New Zealand was 
mainly to understand the situation of 
BTB on the island, the work in Ireland 
was to determine the role of badgers 
in the spread of the disease, and the 
work in Yellowstone was to determine
the role of elk in spreading the disease 
to cattle.
• The advancement in laboratory 
techniques particularly in molecular 
aspects has contributed to several 
available sensitive tests that can help 
us in understanding the epidemiology 
of the disease. The sensitivity of these 
tests, however, has the disadvantages 
to derive the wrong conclusion. I will 
talk later about some of the potential 
problems we faced in our research due 
to the high sensitivity of these tests.
• Another area of advancement in sci­
ence that can help in pursuing our 
eradication effort is the refinement of 
surveillance and survey methods to 
accommodate the needs for detection 
of diseases with a low level of preva­
lence. The use of simulation models to 
determine the best approach to deal 
with this type of diseases has enhanced 
our decision making process to select 
options for controlling these diseases.
In conclusion: Researchers are aware 
of the need for better approaches to 
the BTB control programs and I believe 
that research findings from the last two 
decades have already been imple­
mented in some countries.
Finally I want to talk about our labo­
ratory and our research activities 
related to BTB:
Our overall research aim for BTB is to 
refine existing approaches in control­
ling the disease utilizing new tech­
niques in diagnostic tests and epide­
miological investigations. Specifically, 
we have invested in the following sec­
tions of the disease control program:
1 .Development and validation of a 
multi-antigen panel ELISA as a sero­
logical test for screening of infection in
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cattle, other domestic species, wild 
species, and zoo animals. This work 
has lead to 4 MS thesis with three 
published manuscripts. The sensitivity 
of our ELISA system is in the upper 80s 
but the specificity is in the lower 60s. 
Our conclusion from this effort is that 
we can use 5 antigens that can deter­
mine the exposure to Mycobacterium 
species with varieties of immunity pre­
sentation to determine with some cer­
tainty the specific exposure to M. bovis. 
Our findings, however, confirm the pre­
viously known speculation that humoral 
response is not a good way to deter­
mine the early stage of exposure or in­
fection with TB. Our ELISA system is 
currently used as the screening test for 
infection in elephants, deer, and elk. 
Our intention is to use this test as the 
first screening test in a multiple tests 
system.
2. Use of PCR technique to determine 
the sources of infection in a large dairy 
cattle population in Mexico. We have 
used Random Amplified Polymorphic 
DNA -  Polymerase Chain Reaction 
(RAPD-PCR) to assess phylogenetic 
relationships among 400 M.bovis iso­
lates collected from 6 slaughterhouses 
in Mexico. The aim of this project was 
to determine the validity and reliability 
of this technique in the fingerprinting 
of M.bovis. Isolates were linked to epi­
demiological data that were collected 
through a trace back system in these 6 
geographical regions of Mexico. Our 
conclusion is that this technique is TOO 
sensitive to differentiate these isolates 
and no phylogenetic clustering could 
be associated with their epidemiologi­
cal characteristics. Two manuscripts 
have just recently been published in 
AJVR (Vol 61, No. 1 January 2000: 
Feliciano Milian-Suazo, Salman et al. 
Pages 86-95)
3. Refinement of PCR technique to 
confirm diagnosis of BTB using forma­
lin fixed tissue. Our aim here is to use 
PCR as a direct diagnostic test foTTB 
suspect lesions collected on formalin 
media without processing the samples 
for histopatholgical reading. We have 
successfully used this diagnostic test 
on experim enta lly spiked tissue 
samples with M.bovis and we are in 
the process to validate the test using 
confirmed TB lesions.
4. Utilization of PCR for detection of 
M.bovis and other Mycobacterium spe­
cies in milk and other body flu id 
samples. Dr. Maria Celia Antognoli is 
working on this project. She has com­
pleted her MS thesis in refining this 
method and she has used spiked milk 
to determine the best combination of 
treatment regimens of milk to demon­
strate the validity of her method. She is 
currently working on the validation of 
this technique using milk samples from 
confirmed infected herds in Baja Cali­
fornia, Mexico. We are in the process 
of using the same technique to detect 
M. avian paratb infection in Colorado 
dairy herds.
In conclusion, our research effort has 
lead to several findings that can en­
hance disease control strategies.
It is now most appropriate to 
extend my personal thanks to you all 
for both your presence and attention.
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